Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Management of prostatitis
H S Gurunadha Rao Tunuguntla, C P Evans
International Journal of Cancer
|
August 19, 1991
An autocrine motility factor secreted by the Dunning R-3327 rat prostatic adenocarcinoma cell subtype AT2.1
C P Evans, D S Walsh, E C Kohn
Prostate Cancer and Prostatic Diseases
|
January 30, 2008
Beyond prostate-specific antigen: alternate serum markers
M L Ramírez, E C Nelson, C P Evans
Biochemical and Biophysical Research Communications
|
October 26, 2001
Signal transduction-mediated regulation of urokinase gene expression in human prostate cancer
J A Eandi, J C Yang, C P Evans
Urologic Oncology
|
January 14, 2011
Decreased prostate cancer cell migration by inhibition of the insulin-like growth factor II/Mannose-6-Phosphate receptor
C P Evans, F Elfman, G Cunha, et al.
The Journal of Urology
|
February 1, 1988
Suprarenal occurrence of an adenomatoid tumor
C P Evans, J A Vaccaro, B G Storrs, et al.
BJU International
|
February 27, 2003
Hand-assisted laparoscopic vs the open (flank incision) approach to radical nephrectomy
E Busby, S Das, H S G Rao Tunuguntla, et al.
Cancer Research
|
August 15, 1997
Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade
C P Evans, F Elfman, S Parangi, et al.
International Journal of Cancer
|
December 18, 2001
Regulation of u-PA gene expression in human prostate cancer
C P Evans, E C Stapp, M A Dall'Era, et al.
Angiogenesis
|
May 29, 2004
Angiogenesis is not mediated by prostate cancer neuropeptides
J E Busby, S-J Shih, J C Yang, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Management of prostatitis
H S Gurunadha Rao Tunuguntla, C P Evans
International Journal of Cancer
|
August 19, 1991
An autocrine motility factor secreted by the Dunning R-3327 rat prostatic adenocarcinoma cell subtype AT2.1
C P Evans, D S Walsh, E C Kohn
Prostate Cancer and Prostatic Diseases
|
January 30, 2008
Beyond prostate-specific antigen: alternate serum markers
M L Ramírez, E C Nelson, C P Evans
Biochemical and Biophysical Research Communications
|
October 26, 2001
Signal transduction-mediated regulation of urokinase gene expression in human prostate cancer
J A Eandi, J C Yang, C P Evans
Urologic Oncology
|
January 14, 2011
Decreased prostate cancer cell migration by inhibition of the insulin-like growth factor II/Mannose-6-Phosphate receptor
C P Evans, F Elfman, G Cunha, et al.
The Journal of Urology
|
February 1, 1988
Suprarenal occurrence of an adenomatoid tumor
C P Evans, J A Vaccaro, B G Storrs, et al.
BJU International
|
February 27, 2003
Hand-assisted laparoscopic vs the open (flank incision) approach to radical nephrectomy
E Busby, S Das, H S G Rao Tunuguntla, et al.
Cancer Research
|
August 15, 1997
Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade
C P Evans, F Elfman, S Parangi, et al.
International Journal of Cancer
|
December 18, 2001
Regulation of u-PA gene expression in human prostate cancer
C P Evans, E C Stapp, M A Dall'Era, et al.
Angiogenesis
|
May 29, 2004
Angiogenesis is not mediated by prostate cancer neuropeptides
J E Busby, S-J Shih, J C Yang, et al.
Page
of 4